Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Clinical trial NCT00033956 · SUSPENDED

Trial details

NCT number: NCT00033956
Sponsor: MetaPhore Pharmaceuticals
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

IL-2 Induced Hypotension

Start date: 2001-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.